A detailed history of Sentry Investment Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Sentry Investment Management LLC holds 3,632 shares of VCEL stock, worth $209,057. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,632
Previous 3,632 -0.0%
Holding current value
$209,057
Previous $167,000 8.38%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$41.71 - $52.9 $8,008 - $10,156
-192 Reduced 5.02%
3,632 $167,000
Q4 2023

Jan 30, 2024

BUY
$30.85 - $37.09 $117,970 - $141,832
3,824 New
3,824 $136,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.72B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Sentry Investment Management LLC Portfolio

Follow Sentry Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.